Barcellini, L.; Nardin, S.; Sacco, G.; Ferrante, M.; Rossi, G.; Barletta, G.; Bennicelli, E.; Dellepiane, C.; Tagliamento, M.; Ramella Pollone, B.;
et al. Immune Checkpoint Inhibitors and Targeted Therapies in Early-Stage Non-Small-Cell Lung Cancer: State-of-the-Art and Future Perspectives. Cancers 2025, 17, 652.
https://doi.org/10.3390/cancers17040652
AMA Style
Barcellini L, Nardin S, Sacco G, Ferrante M, Rossi G, Barletta G, Bennicelli E, Dellepiane C, Tagliamento M, Ramella Pollone B,
et al. Immune Checkpoint Inhibitors and Targeted Therapies in Early-Stage Non-Small-Cell Lung Cancer: State-of-the-Art and Future Perspectives. Cancers. 2025; 17(4):652.
https://doi.org/10.3390/cancers17040652
Chicago/Turabian Style
Barcellini, Lucrezia, Simone Nardin, Gianluca Sacco, Michele Ferrante, Giovanni Rossi, Giulia Barletta, Elisa Bennicelli, Chiara Dellepiane, Marco Tagliamento, Beatrice Ramella Pollone,
and et al. 2025. "Immune Checkpoint Inhibitors and Targeted Therapies in Early-Stage Non-Small-Cell Lung Cancer: State-of-the-Art and Future Perspectives" Cancers 17, no. 4: 652.
https://doi.org/10.3390/cancers17040652
APA Style
Barcellini, L., Nardin, S., Sacco, G., Ferrante, M., Rossi, G., Barletta, G., Bennicelli, E., Dellepiane, C., Tagliamento, M., Ramella Pollone, B., Lucente, L., Coco, S., Marconi, S., Santamaria, S., Pariscenti, G. L., & Genova, C.
(2025). Immune Checkpoint Inhibitors and Targeted Therapies in Early-Stage Non-Small-Cell Lung Cancer: State-of-the-Art and Future Perspectives. Cancers, 17(4), 652.
https://doi.org/10.3390/cancers17040652
